HRS-1780 / Jiangsu Hengrui Pharma  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
HRS-1780 / Jiangsu Hengrui Pharma
NCT06039254: Safety and Pharmacokinetics of HRS-1780 in Healthy Subjects and Subjects With Impaired Renal Function

Not yet recruiting
1
27
NA
HRS-1780
Shandong Suncadia Medicine Co., Ltd.
Chronic Kidney Disease
11/23
12/23
NCT05638126: Safety and Tolerance of Increased Doses of HRS-1780 Tablets in Healthy Subjects

Active, not recruiting
1
96
RoW
HRS-1780 table or placebo
Shandong Suncadia Medicine Co., Ltd.
Chronic Kidney Disease
12/23
12/23
NCT06344936: Drug-drug Interaction Study of HRS-1780 Tablets in Healthy Subjects

Not yet recruiting
1
28
RoW
HRS-1780 tablets; Itraconazole capsules; Rifampicin capsules
Shandong Suncadia Medicine Co., Ltd.
Chronic Kidney Disease(CKD)
07/24
07/24

Download Options